Cargando…

Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents

Phage tail-like bacteriocins (PTLBs) are large proteomic structures similar to the tail phages. These structures function in bacterial competition by making pores in the membrane of their competitors. The PTLBs identified in Pseudomonas aeruginosa are known as R-type and F-type pyocins, which have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Blasco, Lucía, de Aledo, Manuel González, Ortiz-Cartagena, Concha, Blériot, Inés, Pacios, Olga, López, María, Fernández-García, Laura, Barrio-Pujante, Antonio, Hernández-Garcia, Marta, Cantón, Rafael, Tomás, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810705/
https://www.ncbi.nlm.nih.gov/pubmed/36596850
http://dx.doi.org/10.1038/s41598-022-27341-1
_version_ 1784863365419499520
author Blasco, Lucía
de Aledo, Manuel González
Ortiz-Cartagena, Concha
Blériot, Inés
Pacios, Olga
López, María
Fernández-García, Laura
Barrio-Pujante, Antonio
Hernández-Garcia, Marta
Cantón, Rafael
Tomás, María
author_facet Blasco, Lucía
de Aledo, Manuel González
Ortiz-Cartagena, Concha
Blériot, Inés
Pacios, Olga
López, María
Fernández-García, Laura
Barrio-Pujante, Antonio
Hernández-Garcia, Marta
Cantón, Rafael
Tomás, María
author_sort Blasco, Lucía
collection PubMed
description Phage tail-like bacteriocins (PTLBs) are large proteomic structures similar to the tail phages. These structures function in bacterial competition by making pores in the membrane of their competitors. The PTLBs identified in Pseudomonas aeruginosa are known as R-type and F-type pyocins, which have a narrow spectrum of action. Their specificity is determined by the tail fiber and is closely related to the lipopolysaccharide type of the target competitor strain. In this study, the genome sequences of 32 clinical of P. aeruginosa clinical isolates were analysed to investigate the presence of R-type and F-type pyocins, and one was detected in all strains tested. The pyocins were classified into 4 groups on the basis of the tail fiber and also the homology, phylogeny and structure of the cluster components. A relationship was established between these groups and the sequence type and serotype of the strain of origin and finally the killing spectrum of the representative pyocins was determined showing a variable range of activity between 0 and 37.5%. The findings showed that these pyocins could potentially be used for typing of P. aeruginosa clinical isolates, on the basis of their genomic sequence and cluster structure, and also as antimicrobial agents.
format Online
Article
Text
id pubmed-9810705
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98107052023-01-05 Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents Blasco, Lucía de Aledo, Manuel González Ortiz-Cartagena, Concha Blériot, Inés Pacios, Olga López, María Fernández-García, Laura Barrio-Pujante, Antonio Hernández-Garcia, Marta Cantón, Rafael Tomás, María Sci Rep Article Phage tail-like bacteriocins (PTLBs) are large proteomic structures similar to the tail phages. These structures function in bacterial competition by making pores in the membrane of their competitors. The PTLBs identified in Pseudomonas aeruginosa are known as R-type and F-type pyocins, which have a narrow spectrum of action. Their specificity is determined by the tail fiber and is closely related to the lipopolysaccharide type of the target competitor strain. In this study, the genome sequences of 32 clinical of P. aeruginosa clinical isolates were analysed to investigate the presence of R-type and F-type pyocins, and one was detected in all strains tested. The pyocins were classified into 4 groups on the basis of the tail fiber and also the homology, phylogeny and structure of the cluster components. A relationship was established between these groups and the sequence type and serotype of the strain of origin and finally the killing spectrum of the representative pyocins was determined showing a variable range of activity between 0 and 37.5%. The findings showed that these pyocins could potentially be used for typing of P. aeruginosa clinical isolates, on the basis of their genomic sequence and cluster structure, and also as antimicrobial agents. Nature Publishing Group UK 2023-01-03 /pmc/articles/PMC9810705/ /pubmed/36596850 http://dx.doi.org/10.1038/s41598-022-27341-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Blasco, Lucía
de Aledo, Manuel González
Ortiz-Cartagena, Concha
Blériot, Inés
Pacios, Olga
López, María
Fernández-García, Laura
Barrio-Pujante, Antonio
Hernández-Garcia, Marta
Cantón, Rafael
Tomás, María
Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
title Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
title_full Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
title_fullStr Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
title_full_unstemmed Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
title_short Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
title_sort study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810705/
https://www.ncbi.nlm.nih.gov/pubmed/36596850
http://dx.doi.org/10.1038/s41598-022-27341-1
work_keys_str_mv AT blascolucia studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT dealedomanuelgonzalez studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT ortizcartagenaconcha studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT bleriotines studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT paciosolga studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT lopezmaria studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT fernandezgarcialaura studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT barriopujanteantonio studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT hernandezgarciamarta studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT cantonrafael studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents
AT tomasmaria studyof32newphagetaillikebacteriocinspyocinsfromaclinicalcollectionofpseudomonasaeruginosaandoftheirpotentialuseastypingmarkersandantimicrobialagents